Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients' Outcome; a Cross-sectional Study

被引:12
作者
Alizadeh, Nafiseh [1 ]
Tabatabaei, Fatemeh-sadat [2 ]
Azimi, Amirali [3 ]
Faraji, Neda [4 ]
Akbarpour, Samaneh [5 ]
Dianatkhah, Mehrnoush [6 ]
Moghaddas, Azadeh [7 ]
机构
[1] Univ Tehran Med Sci, Baharlou Hosp, Dept Pharmaceut Care, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Mens Hlth & Reprod Hlth Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Baharlou Hosp, Dept Internal Med, Tehran, Iran
[5] Univ Tehran Med Sci, Baharlou Hosp, Occupat Sleep Res Ctr, Tehran, Iran
[6] Isfahan Univ Med Sci, Dept Clin Pharm, Esfahan, Iran
[7] Isfahan Univ Med Sci, Dept Clin Pharm & Pharm Practice, Sch Pharm & Pharmaceut Sci, Canc Prevent Res Ctr,Seyyed Al Shohada Hosp, Esfahan, Iran
关键词
SerumAlbumin; L-Lactate Dehydrogenase; COVID-19; Prognosis; Emergency Service; Hospital; SEPSIS;
D O I
10.22037/aaem.v10i1.1646
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes. Methods: This retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction ofmortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first: LAR<101.46, second: 101.46 <= LAR< 148.78, and third group: LAR >= 148.78. Logistic regression analysis was used to identify the association between tertiles of LAR, as well as the relationship between each one-unit increase in LAR with mortality and ICU admission in three models, based on potential confounding variables. Results: A total of 477 patients were included. Among all patients, 100 patients (21%) died, and 121 patients (25.4%) were admitted to intensive care unit (ICU). In the third group, the risk of mortality and ICU admission increased 7.78 times (OR=7.78, CI: 3.95-15.26; p <0.0001) and 4.49 times (OR=4.49, CI: 2.01-9.04; p <0.0001), respectively, compared to the first group. The AUC of LAR for prediction of mortality was 0.768 (95% CI 0.69- 0.81). LAR >= 136, with the sensitivity and specificity of 72% (95%CI: 62.1-80.5) and 70% (95%CI: 64.9-74.4), respectively, was the optimal cut-off value for predicting mortality. Conclusion: High LAR was associated with higher odds of COVID-19 mortality, ICU admission, and length of hospitalization. On-admission LAR levels might help health care workers identify critical patients early on.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Alizadeh N, 2022, J PHARM CARE, V10, P11
  • [2] Serum albumin is a strong predictor of sepsis outcome in elderly patients
    Arnau-Barres, Isabel
    Guerri-Fernandez, Robert
    Luque, Sonia
    Sorli, Luisa
    Vazquez, Olga
    Miralles, Ramon
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (04) : 743 - 746
  • [3] Cascella M, 2022, STATPEARLS
  • [4] Chen Cheng-Yu, 2005, J Chin Med Assoc, V68, P4, DOI 10.1016/S1726-4901(09)70124-8
  • [5] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
    Chen, Nanshan
    Zhou, Min
    Dong, Xuan
    Qu, Jieming
    Gong, Fengyun
    Han, Yang
    Qiu, Yang
    Wang, Jingli
    Liu, Ying
    Wei, Yuan
    Xia, Jia'an
    Yu, Ting
    Zhang, Xinxin
    Zhang, Li
    [J]. LANCET, 2020, 395 (10223) : 507 - 513
  • [6] Fair Allocation of Scarce Medical Resources in the Time of Covid-19
    Emanuel, Ezekiel J.
    Persad, Govind
    Upshur, Ross
    Thome, Beatriz
    Parker, Michael
    Glickman, Aaron
    Zhang, Cathy
    Boyle, Connor
    Smith, Maxwell
    Phillips, James P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) : 2049 - 2055
  • [7] Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.46234/ccdcw2020.032, 10.3760/cma.j.issn.0254-6450.2020.02.003]
  • [8] Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
    Guo, Tao
    Fan, Yongzhen
    Chen, Ming
    Wu, Xiaoyan
    Zhang, Lin
    He, Tao
    Wang, Hairong
    Wan, Jing
    Wang, Xinghuan
    Lu, Zhibing
    [J]. JAMA CARDIOLOGY, 2020, 5 (07) : 811 - 818
  • [9] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
    Henry, Brandon Michael
    de Oliveira, Maria Helena Santos
    Benoit, Stefanie
    Plebani, Mario
    Lippi, Giuseppe
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1021 - 1028
  • [10] Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19
    Hou, H.
    Zhang, B.
    Huang, H.
    Luo, Y.
    Wu, S.
    Tang, G.
    Liu, W.
    Mao, L.
    Mao, L.
    Wang, F.
    Sun, Z.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 201 (01) : 76 - 84